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Received 30 August 2010; accepted 17 September 2010AbstractBackground: Only a small proportion of patients with end-stage renal disease can receive kidney transplants because of insufficiency of kidney
donors in Taiwan. Hospitals compete with each other for kidney transplant surgeries. This study examined the association between hospital
surgical volume of kidney transplants and patients’ outcomes and utilizations.
Methods: Claims data of all kidney transplants between 1996 and 2003 were retrieved from the National Health Insurance Research Database for
analysis. Every kidney recipient was followed up for 3 years until the end of 2006. Hospitals were classified as high-surgical-volume hospitals
(HSVHs) if their total number of kidney transplants was 72 or more between 1996 and 2003; otherwise, they were grouped into the low-surgical-
volume hospitals (LSVHs). The differences in quality (infection rate, graft rejection rate, readmission rate, mortality, and survival rates of
patients and transplanted grafts at 1, 2, and 3 years after surgery) and cost (length of stay, total transplant cost, and annual medical cost for 3
years) of kidney transplants were examined between the two groups.
Results: Totally, 1,060 kidney transplants were analyzed, 77% of which were conducted at 6 of 29 qualified hospitals. Compared with those
performed at LSVHs, transplant surgeries at HSVHs were associated with lower bacteria (35.1% vs. 48.8%, p< 0.001), fungus (0.2% vs. 1.3%,
p¼ 0.008), and cytomegalovirus (1.2% vs. 4.6%, p¼ 0.003) infection; lower mortality (1.1% vs. 5.0%, p< 0.001); and higher 1-, 2-, and 3-year
survival rates for patients (96.3%, 94.1%, 93.5% vs. 91.2%, 87.1%, 85.4%, respectively, p< 0.01) and for transplanted grafts (89.5%, 81.0%,
80.5% vs. 85.8%, 74.6%, 73.3%, respectively, p< 0.015). The transplant cost was lower for HSVHs than for LSVHs (New Taiwan $221,977 vs.
New Taiwan $257,992, p¼ 0.018).
Conclusion: Seventy-seven percent of kidney transplant surgeries were concentrated at six hospitals in Taiwan. There were significant differ-
ences in quality and cost between HSVHs and LSVHs. We suggest adopting volume-based strategies for nonurgent kidney transplants.
Copyright  2011 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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End-stage renal disease (ESRD) is a severe medical and
public health issue in Taiwan, with the highest incidence and
prevalence rates in the world.1 The medical cost of ESRD
and its complications was about New Taiwan (NT) $32.8Chinese Medical Association. All rights reserved.
t
nal
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roughly 7.6% of the total National Health Insurance budget
and incurring the highest cost for a single disease.2
Kidney transplant is widely believed to be the best thera-
peutic option for patients with ESRD among all kidney
replacement therapies.3 Patients who receive kidney trans-
plants have higher satisfaction rates, better quality of life, and
lower long-term utilization and costs than those who receive
dialysis therapy.4 There were approximately 59,000 patients
with ESRD in Taiwan in 2008, but the number of organ donors
was around 200 a year.2 As a result, hospitals compete with
each other for the limited donors.
Twenty-nine hospitals are qualified by the Department of
Health (DOH) to perform kidney transplant surgeries in
Taiwan. There is no volume threshold for kidney transplant at
the hospital level, so any qualified hospital can perform
transplant surgeries as long as matched donors are found. The
Taiwan Organ Registry and Sharing Center was established in
2003 with the aims to develop a nationwide and comprehen-
sive registry of patients waiting for organ transplant and
improving the efficiency and equality of donated organ sharing
among hospitals. Nevertheless, large-scale hospitals are used
to having more trauma patients and invest more effort in
activities promoting organ donations and thus have more
opportunities to get matched organs than small-scale hospitals.
The limited number of donors and uneven distribution of
kidney transplant surgeries among hospitals have raised public
concern regarding whether recipients can obtain the same
quality of care at high- and low-volume hospitals.
The differences in quality and cost of kidney transplants
between high- and low-volume hospitals have not been
examined in Taiwan. Although many studies in other countries
have demonstrated that patients who receive surgery at higher
volume hospitals are more likely to have better outcomes,5e13
an increasing number of studies have obtained contradictory
findings.14,15 Because the transplant volume of Taiwan’s
hospitals is smaller than that of other countries, the “higher
volume and better outcomes” association may not exist for
kidney transplant surgeries in Taiwan. Therefore, the aim of
this study was to examine the association between hospital
surgical volume of kidney transplants and patients’ outcomes
and costs.
2. Methodsps
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ye2.1. Study design and data sourcesndikf
o
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Hospitals qualified to perform kidney transplants in Taiwan 
Fig. 1. Distribution of surgical volume for kidney transplants of 29 qualified
hospitals in Taiwan from 1996 to 2003.We conducted a retrospective analysis using claims data for
kidney transplants on a national basis in Taiwan. These data
were reported to the National Health Insurance by hospitals
after kidney transplants for claim purposes. Patients with
a confirmed diagnosis of ESRD who received a kidney
transplant between January 1, 1996 and December 31, 2003
were included in this study. Every patient’s condition was
followed up for a maximum of 3 years after transplant or until
December 31, 2006 to confirm whether they died during the
transplant itself or from its complications during the 3-yearobservation period. Patients younger than 18 years and those
receiving a second transplant were not included in the study.
The source of the analytic data was a longitudinal data set
prepared by Taiwan’s National Healthcare Research Institute
(NHRI), which is available to researchers interested in
observing longitudinal changes in medical outcomes and cost.
The application of the claims data of patients with renal
transplant followed the National Healthcare Research Insti-
tute’s regulations. The applied files contained individual
subscription information and demographic factors, including
gender, date of birth, and location of the transplant hospital.
The claims files contained comprehensive records of inpatient
care, ambulatory care, and the pharmacies. The files also
included the date of transplant surgery, International Classifi-
cation of Diseases, version 9 diagnosis codes for ESRD, and
claimed medical expenses for each encounter. Individuals’
identifiers in this data set were encrypted to protect their
privacy.2.2. High- and low-volume hospitalsThis study was designed to compare the differences in
quality and utilization of kidney transplantation surgeries at
the hospital level. The total surgical volume of kidney trans-
plants for every qualified hospital between 1996 and 2003 was
counted and plotted (Fig. 1). Six hospitals performed consid-
erably more transplant surgeries than the other 23 hospitals.
Therefore, we divided the hospitals into two volume groups,
namely, high-surgical-volume hospitals (HSVHs) and low-
surgical-volume hospitals (LSVHs) using the cutoff value of
72 cases.2.3. Quality and cost measuresTwo groups of outcome variables were used to measure the
quality of kidney transplant at the hospital level. First, the
complications of surgeries, including bacterial infection,
fungal infection, cytomegalovirus (CMV) infection, rejection
Table 1
The comparison of patients’ characteristics between LSVHs and HSVHs in Taiwan from 1996 to 2003
Characteristics LSVHs HSVHs p
Number of hospitals 23 6
Total number of kidney transplants 240 820
Number of kidney transplants per hospital (mean SD) 10.4 9.1 136.7 99.0 <0.001
Patient characteristics
Male/female 113/127 398/422 0.692
Age (mean SD) 37.7 10.1 39.6 10.1 0.010
Dialysis time before transplant (mo) 28.9 22.8 28.4 20.2 0.756
Comorbidity burdens (Charlson score) 0.6 1.0 0.6 1.1 0.871
HSVH¼ high-surgical-volume hospital; LSVH¼ low-surgical-volume hospital; SD¼ standard deviation.
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days after discharge, and mortality. Second, the survival rates,
including the survival rates for patients and transplanted grafts
at 1, 2, and 3 years after surgery, respectively. Utilization
variables included the length-of-hospital stay for the transplant
surgery, total medical cost for the transplant, and annual
medical cost for 3 years after the transplant. All necessary
information for the aforementioned measures was retrieved
from the claims data set.2.4. Statistical analysisThe first step was to describe and compare the demographic
information and disease characteristics of patients who
received kidney transplants between the HSVHs and LSVHs,
including gender, age, duration of dialysis therapy before
transplant, and comorbidity burden as measured by the
Charlson Comorbidity Index scores.16 The second step was to
compare the quality and utilization variables between the twoTable 2
The comparison of quality and utilizations of kidney transplantation surgeries betw
Parameters LSVHs
Complications
Bacterial infection (%) 117 (48.8)
Fungal infection (%) 3 (1.3)
CMV infection (%) 11 (4.6)
Graft rejection (%) 26 (10.8)
Mortality (%) 12 (5.0)
Readmission in 14 d (%) 25 (10.4)
Patient survival
1-yr survival (%) 219 (91.2)
2-yr survival (%) 209 (87.1)
3-yr survival (%) 205 (85.4)
Graft survival
1-yr survival (%) 206 (85.8)
2-yr survival (%) 179 (74.6)
3-yr survival (%) 176 (73.3)
Utilizations and cost
Length of stay (d) 21.9 15.3
Transplant cost (NT$) 257,992 203,865
1-yr cost (NT$) 425,981 425,980
2-yr cost (NT$) 318,998 241,959
3-yr cost (NT$) 302,101 212,593
HSVH¼ high-surgical-volume hospital; LSVH¼ low-surgical-volume hospital; CMvolume groups using an independent t-test. Accumulative
patient and graft survival rates for each year were calculated
and plotted using the Kaplan-Meier survival analysis. The log-
rank analysis was used to examine the differences in survival
between hospital groups. All of these calculations were per-
formed using SPSS software version 15.0 (SPSS Inc., Chi-
cago, IL, USA).
3. Results3.1. Demographic and comorbidity analysisA total of 1,060 kidney transplant surgeries were included
in this analysis. The average dialysis time before transplant
was 28.5 months, and the comorbidity burden was 0.6 by the
Charlson score. The HSVHs were all large-scale medical
centers: three in northern, one in middle, and two in southern
Taiwan. About 77% of the kidney transplants were performed
at the six HSVHs; the other 23% were performed at the 23een LSVHs and HSVHs
HSVHs p
288 (35.1) <0.001
2 (0.2) 0.008
10 (1.2) 0.003
127 (15.5) 0.003
9 (1.1) <0.001
82 (10.0) 0.903
790 (96.3) 0.002
772 (94.1) <0.001
767 (93.5) <0.002
734 (89.5) 0.132
664 (81.0) 0.036
660 (80.5) 0.019
19.9 14.0 0.069
221,977 207,260 0.018
410,765 263,406 0.431
317,056 194,142 0.898
303,200 199,122 0.941
V¼ cytomegalovirus; NT¼New Taiwan.
Fig. 2. The survival curve of patients who received kidney transplant at the
HSVHs and LSVHs. There was significant difference between the two groups
( p< 0.001 by log-rank test). HSVH¼ high-surgical-volume hospital;
LSVH¼ low-surgical-volume hospital.
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HSVHs and 10.4 9.1 for LSVHs during 8 years. Table 1 lists
the differences between HSVHs and LSVHs in terms of
patients’ demographic and disease characteristics. The mean
age of the recipients was higher for HSVHs than for LSVHs
(39.6 vs. 37.7, p¼ 0.01). Otherwise, there was no statistical
difference in recipients’ gender, duration of dialysis before
transplant, and comorbidity burdens between groups.3.2. Transplant surgery complications analysisTable 2 lists the differences in quality and utilization
between HSVHs and LSVHs. Patients who received kidney
transplants at the LSVHs were more likely to get bacterial,
fungal, and cytomegalovirus infections than those at the
HSVHs ( p< 0.01 for all). The immediate graft rejection rateFig. 3. The survival curves of transplanted kidney grafts at the HSVHs and
LSVHs. There was significant difference between the two groups ( p¼ 0.016
by log-rank test). HSVH¼ high-surgical-volume hospital; LSVH¼ low-
surgical-volume hospital.was higher for HSVHs than for LSVHs (15.5% vs. 10.8%,
p¼ 0.003), but the mortality rate at the LSVHs was 4.5 times
higher than that at the HSVHs (5.0% vs. 1.2%, p¼ 0.001).3.3. Survival analysisThe average survival rate of all patients was 95.2% at 1
year, 92.5% at 2 years, and 91.7% at 3 years after trans-
plantation. Patients at HSVHs displayed higher 1-, 2-, and 3-
year survival rates than those at LSVHs, and the difference
reached statistical significance (Table 2). The survival rate of
the transplanted grafts was 88.7% at 1 year, 79.5% at 2 years,
and 91.7% at 3 years, and HSVHs also displayed higher
survival patient rates than LSVHs except in the first year
(Table 2). The Kaplan-Meier survival curves illustrate that
HSVHs exhibited a higher patient (Fig. 2, p< 0.001) and graft
(Fig. 3, p¼ 0.016) survival rate than LSVHs at every time
interval.3.4. Utilization analysisThe average length-of-hospital stay at HSVHs was 2 days
less than that at LSVHs (19.9 vs. 21.9 days, p¼ 0.069). The
medical cost for kidney transplant surgery was significantly
lower at the HSVHs than the LSVHs (NT$ 221,977 vs. NT$
257,992, p¼ 0.018), but the difference in posttransplant cost
did not reach statistical significance (Table 2).
4. Discussion
ESRD has significant influence on patients’ quality of life,
and related utilization of medical resources creates a consid-
erable financial burden on health care systems, whether in
Taiwan or elsewhere.2,17 Around 58,000 patients were on
dialysis therapy in 2008 but only about 3% of them had the
opportunity to receive transplantation surgery. Because
hospital’s surgical quality information for kidney trans-
plantation has not been released to the public, a hospital’s
surgical volume of kidney transplants has become a conve-
nient proxy quality indicator for patients and donors. This
study revealed that kidney transplants performed at high-
volume hospitals were more likely to result in fewer surgical
complications, lower mortality, and higher survival for patients
and transplanted grafts than those performed at low-volume
hospitals. Transplant surgery costs were also lower at high-
than low-volume hospitals.
These findings are similar to those of other volume-
outcome studies for transplantation 5e8 and high-risk
surgeries11,13 in other countries. Kidney transplant outcome is
determined by a recipient’s health status, surgical techniques,
competency of the surgeons and staff, multidisciplinary care,
infection control, and the ability to manage graft rejection
after surgery. Although the mean age of the kidney recipients
was older and the initial graft rejection rate was higher for
patients at HSVHs than at LSVHs, the survival rates for
recipients and grafts were significantly better at HSVHs than
LSVHs.
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hypothesis, in that higher volume providers develop more
effective skills and treatments that result in better
outcomes.18,19 It is plausible that lower volume providers are
at a disadvantage because they have fewer opportunities to
develop the necessary skills for successful transplants.20 In
this study, the surgeons and the transplant team at the high-
volume hospitals likely had the necessary facilities, equip-
ment, surgical techniques, and experience in managing trans-
plant risks and complications, such as old age, graft rejections,
and all kinds of infections. Given fewer complications and
better infection control, kidney transplants at the HSVHs
resulted in shorter lengths of stay and lower costs than those at
the LSVHs.
The “higher volume, better outcome” relationship has also
been explained in part by the ‘‘selective referral” hypothesis,
in that volume could be higher in hospitals with better
outcomes because patients seek care at facilities with reputa-
tions for better performance.21 Many large-scale hospitals
have the resources to promote organ donation; and thus
patients with ESRD, register and wait for kidney transplants at
hospitals renowned for kidney transplantation. Cadaver donors
are the main organ sources in Taiwan. Thus, many people are
willing to donate organs to hospitals with strong reputations in
kidney transplants. Sometimes, the donors are at other
hospitals, and a quick response transplant team is usually
readily available from the HSVHs to get the donated organs.
Because it costs a lot to develop and maintain an experienced
transplant team, LSVHs gradually lose the edge and cannot
compete for the limited numbers of donated organs. The
“selective referral” hypothesis can partially explain the
concentration of kidney transplants in six hospitals, although
other hospitals have the techniques and facilities to perform
them as well.
The study results have high reliability and external validity
because the analysis was based on nationwide claim data from
the single-payer insurance system in Taiwan. However, inter-
pretation of these study findings should be cautious because
patient and kidney graft survival is associated with many
factors beyond the scope of secondary data analysis. First, the
quality of donated kidneys significantly affects transplant
prognosis, as do other relevant factors, including donor age,
gender, species, cause of brain death, HLA typing, cadaver or
living kidney, and cold ischemic time during transplant.22 This
study could not clarify these factors using the claim data.
Second, the volume threshold used in this study was not based
on scientific evidence but a convenient cutoff value (Fig. 1).
The collected number of kidney transplants was inadequate to
study the learning curve of the surgery for hospitals across
time. Therefore, the minimum number of accumulated kidney
transplant surgeries at the hospital level above which the
quality of transplant, according to survival of patients and
grafts, can attain a certain high standard has yet to be clarified.
A hospital’s kidney transplant success rate is usually
considered a quality landmark in risky surgery and multidis-
ciplinary care, and it is also the first step toward other organ
transplantation surgeries in Taiwan. The capability of hospitalfacilities, equipment, and personnel for kidney transplant are
inspected and accredited to ensure quality and patient safety in
Taiwan. Nevertheless, the appropriate number of hospitals
allowed to perform kidney transplants is still under debate.
Several volume-based selective referral or regionalization
policies have been implemented for certain risky surgeries in
the United States.23 Accumulating evidence has shown that
volume-based referral can save more patient lives.11,13 Further
observational studies show that the beneficial effects of high-
volume hospitals are particularly concentrated in a subgroup
of moderate- to high-risk patients.24,25
This study highlights the fact that nearly 80% of the
surgeries were performed at six HSVHs, which provided better
quality of care than LSVHs. If all kidney transplants were
performed at these HSVHs, more patients and transplanted
grafts would be saved and costs could be contained. Therefore,
we suggest that policy makers consider the following volume-
based strategies to improve the quality of kidney transplants.
First, the DOH can consider adopting a “center of excellence”
policy, that is, regionalizing nonurgent kidney transplant
surgeries to hospitals that have performed kidney transplant
surgeries above a certain volume threshold. This volume
threshold can be decided by health care authorities, transplant
expert groups, hospitals, and patient representatives. Urgent
transplant surgeries and those in the rural areas are waived for
the volume standard. Second, the “center of excellence”
hospital should be accountable for regional kidney transplant
quality and outcomes. All high-risk patients shall be referred
to high-volume hospitals for intensive care. If kidney trans-
plants for high-risk patients are allowed to be performed at
low-volume hospitals, they shall be supervised by the “center
of excellence” hospitals. Third, the DOH can use a “certificate
of need” policy to review proposals for new construction and
expand services in an effort to control costs and to improve
kidney transplant quality. Such policies have been proved to be
beneficial to high-risk patients receiving heart trans-
plantation,26 pancreas cancer,27 and cardiac surgeries.28
In conclusion, this study highlights the fact that 77% of all
kidney transplant surgeries were concentrated at only six
hospitals in Taiwan. Patients who received kidney transplants
at high-volume hospitals were more likely to have fewer
surgical complications, lower mortality, higher survival rates,
and lower costs than those at the low-volume hospitals. We
suggest adopting volume-based strategies to ensure the quality
of nonurgent kidney transplant surgeries and to facilitate the
highest utilization of limited kidney donors. Nevertheless,
hospital kidney transplant volume is just a proxy quality
indicator on the population basis. The ultimate goal is for
recipients and donors to have access to comprehensive and
transparent quality information of kidney transplants.Acknowledgments
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